Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Stenzel

Showing results (151-160 of 200) with videos related to

Pageof 20
Sort By:
American Journal of Hypertension|May 1, 1989
Hypertension in kidney transplant recipients. Effect on long-term renal allograft survivalJ S Cheigh, R H Haschemeyer, J C Wang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 1998
Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patientsR M Bologa, D M Levine, T S Parker, et al.
Transplantation Proceedings|March 1, 1977
Biologic immunosuppression in renal transplantation using retroplacental (maternal) source gamma globulinR R Riggio, S D Saal, K H Stenzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2J C Wang, A Walle, A Novogrodsky, et al.
Lancet (London, England)|February 4, 1978
Improved survival-rates in presensitised recipients of kidney transplants by immunosuppression with maternal-source gamma-globulinR R Riggio, S J Kim, S D Saal, et al.
The American Journal of Medicine|December 1, 1987
Adoptive immunotherapy for stage IV renal cell carcinoma: a novel protocol utilizing periodate and interleukin-2-activated autologous leukocytes and continuous infusions of low-dose interleukin-2J Wang, A Walle, B Gordon, et al.
Annals of Surgery|February 1, 1972
Viral syndromes and renal homograft rejectionD S David, S J Millian, J C Whitsell, et al.
Kidney International|September 1, 1980
Kidney transplant nephrotic syndrome: relationship between allograft histopathology and natural courseJ S Cheigh, J Mouradian, M Susin, et al.
Transplantation Proceedings|February 1, 1987
Optimization of donor specific blood transfusion in kidney transplantationJ S Cheigh, M Suthanthiran, W T Stubenbord, et al.
Transplantation Proceedings|February 1, 1991
Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporineJ S Cheigh, M Suthanthiran, M Fotino, et al.
Pageof 20

Showing results (151-160 of 200) with videos related to

Sort By:
Pageof 20
American Journal of Hypertension|May 1, 1989
Hypertension in kidney transplant recipients. Effect on long-term renal allograft survivalJ S Cheigh, R H Haschemeyer, J C Wang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 1998
Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patientsR M Bologa, D M Levine, T S Parker, et al.
Transplantation Proceedings|March 1, 1977
Biologic immunosuppression in renal transplantation using retroplacental (maternal) source gamma globulinR R Riggio, S D Saal, K H Stenzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2J C Wang, A Walle, A Novogrodsky, et al.
Lancet (London, England)|February 4, 1978
Improved survival-rates in presensitised recipients of kidney transplants by immunosuppression with maternal-source gamma-globulinR R Riggio, S J Kim, S D Saal, et al.
The American Journal of Medicine|December 1, 1987
Adoptive immunotherapy for stage IV renal cell carcinoma: a novel protocol utilizing periodate and interleukin-2-activated autologous leukocytes and continuous infusions of low-dose interleukin-2J Wang, A Walle, B Gordon, et al.
Annals of Surgery|February 1, 1972
Viral syndromes and renal homograft rejectionD S David, S J Millian, J C Whitsell, et al.
Kidney International|September 1, 1980
Kidney transplant nephrotic syndrome: relationship between allograft histopathology and natural courseJ S Cheigh, J Mouradian, M Susin, et al.
Transplantation Proceedings|February 1, 1987
Optimization of donor specific blood transfusion in kidney transplantationJ S Cheigh, M Suthanthiran, W T Stubenbord, et al.
Transplantation Proceedings|February 1, 1991
Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporineJ S Cheigh, M Suthanthiran, M Fotino, et al.
Pageof 20